Rockwell Medical Technologies (RMTI) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
BTIG Affirms Rockwell Medical Tech (RMTI) at 'Buy'; Still Sees as Undervalued with Two Approved Product
November 8, 2016 1:31 PM ESTBTIG affirms Rockwell Medical Technologies (Nasdaq: RMTI) at Buy with a price target of $12 after the company posted Q3 results on Monday night.
Analyst Ling Wang summarized: Rockwell Medical reported 3Q16 EPS of $(0.09) vs. consensus of $(0.10) and our estimate of $(0.11),... More
BofA/Merrill Lynch Downgrades Rockwell Medical Technologies (RMTI) to Underperform
November 8, 2016 7:09 AM ESTBofA/Merrill Lynch downgraded Rockwell Medical Technologies (NASDAQ: RMTI) from Neutral to Underperform with a price target of $5.00.
For an analyst ratings summary and ratings history on Rockwell Medical Technologies click here. For more ratings news on Rockwell Medical Technologies click here.
Shares of Rockwell Medical Technologies closed at $5.66 yesterday.
... More